• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Analyst Comment

Dagens aktienyheder 22/02

By HC Andersen Capital

Dagens aktienyheder 22/02: Bawat A/S og Zerion Pharma

Bawat A/S var i går ude med regnskabet for Q4 2022 efter, at selskabet i januar var ude med hovedtal for 2022 og guidance for 2023. I den forbindelse interviewede vi Bawats CEO til en gennemgang af resultaterne, den seneste aktivitet samt forventningerne til 2023. Se præsentationen her: https://lnkd.in/gutF_nuF

Zerion Pharma: Private Placement round of € 2-3m - watch here: https://lnkd.in/dcT_yEBe

Disclaimer: HC Andersen Capital modtager betaling fra selskaberne for en Digital IR aftale.

Jesper Thomsen - 22/02 2023 kl. 08:57.

Stay up to date
Bawat Water Technologies
Zerion Pharma